Prospect Capital’s Strategic Pivot: A High-Cost Debt Overhaul
22.12.2025 - 06:52:04Prospect Capital US74348T1025
Prospect Capital is executing a significant financial restructuring, aiming to extend its debt maturities through a new issuance of unsecured notes. This maneuver, however, comes with a substantial increase in interest costs, creating a complex trade-off for the business development company. Concurrent share buybacks of older debt and a postponed annual meeting have added layers of uncertainty for investors.
The core of the strategy involves issuing new debt to manage older obligations. On December 22, 2025, the company set the trade date for a new InterNotes offering. This issuance comprises three tranches with fixed coupons: 6.25% maturing in 2028, 6.50% in 2030, and 6.75% in 2032. The final settlement is scheduled for December 26, 2025. Management intends to use the proceeds to partially repay older liabilities and lengthen the company's maturity profile.
In preparation, Prospect Capital has been active in the debt markets in recent weeks. It repurchased $20.3 million of its 3.437% notes due 2028 and $34.8 million of its 3.364% notes due 2026. These buybacks were executed at prices ranging from 88.95% to 97.06% of their face value. Furthermore, international placements of its 5.50% Series A notes provided approximately $159.8 million in net proceeds, earmarked for refinancing revolving credit facilities.
Key Data Points:
* New Debt Terms: Coupons of 6.25% (2028), 6.50% (2030), and 6.75% (2032).
* Recent Buybacks: $20.3 million (2028 notes) and $34.8 million (2026 notes) at a discount.
* Dividend: The monthly distribution remains unchanged at $0.0450 per common share.
* Shareholder Meeting: The adjourned annual meeting is set to reconvene on January 8, 2026.
The objective is clear: push out debt maturities and retire some discounted obligations. The consequence is a higher ongoing interest burden due to the newly issued, higher-coupon securities.
Should investors sell immediately? Or is it worth buying Prospect Capital?
Market Performance and Analyst Sentiment
The equity market has reacted negatively to these developments. Prospect Capital's shares have declined in 8 of the last 10 trading sessions, resulting in a cumulative loss of approximately -7.87% over that period. On the final trading day of the previous week, the stock fell 3.53% on elevated volume of around 6 million shares, an increase of about 2 million. Technically, the stock is in a downtrend, trading below its 200-day moving average and roughly 55% below its 52-week high.
Selected Financial Metrics:
* Recent Close: €2.10; Year-to-Date Performance: -50.47%.
* Net Asset Value (NAV): Declined to $6.45 per common share from $6.56.
* Common Shares Outstanding: 465,087,009.
* Capital Structure: Common equity ranks behind several series of preferred stock, including the 5.50% Series A1, 5.35% Series A, and 7.50% Series A5.
* Analyst Consensus: The prevailing view among the five analysts covering the stock is a "Sell" rating.
The persistent selling pressure appears linked to the combination of rising financing expenses, a contracting net asset value, and a multi-layered capital structure.
The Path Forward
The immediate focus for investors is on two key dates: the settlement of the InterNotes offering on December 26, 2025, and the resumption of the annual meeting on January 8, 2026. If the capital allocation plan succeeds—refinancing revolving lines and retiring discounted bonds—the company's debt maturity schedule will improve. However, this stability is purchased at a price: a heavier interest load from the new, higher-yielding instruments. The balance sheet gains temporal relief, but the financial flexibility comes at a significantly increased cost of capital.
Ad
Prospect Capital Stock: Buy or Sell?! New Prospect Capital Analysis from December 22 delivers the answer:
The latest Prospect Capital figures speak for themselves: Urgent action needed for Prospect Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 22.
Prospect Capital: Buy or sell? Read more here...


